RxDoctor Payments Data

Martin Schaeffer, MD

Physical Medicine & Rehabilitation · Liverpool, NYNPI 1881621472

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $37,044 of the $40,529 with a category attached, or 91.4%. AbbVie accounts for 96.1% of it on its own, with 10 other manufacturers making up the rest. Among physical medicine & rehabilitation clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$40,529in general payments, 2019–2025

Across 151 payments — averaging $268.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$39K
  • Stimwave Technologies Incorporated$982
  • Si-bone, Inc.$149
  • Foundation Fusion Solutions, LLC$113
  • SPR Therapeutics, Inc$98
  • Spinal Simplicity, LLC$87
  • plus $142 from 5 others

What the payments were for

  • Speaking & faculty fees$37,04491%
  • Travel & lodging$1,0122%
  • Food & beverage$2,4736%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,529 in reported general payments places this provider in the 95th percentile of 872 physical medicine & rehabilitation providers in New York.

See all physical medicine & rehabilitation providers in New York

Medicare billing

Part B allowed, 2024
$229,307
Medicare patients
586
Services billed
6,399

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate12$10,308
Celecoxib211$4,179
Pregabalin83$3,316
Lidocaine35$3,005
Tramadol Hcl ErTramadol Hcl16$1,879
Gabapentin149$1,849
Naloxone Hcl22$1,709
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen79$1,173
Duloxetine Hcl23$856
Tizanidine Hcl77$827
Oxycodone Hcl43$810
Cyclobenzaprine Hcl60$713
Baclofen46$539
Morphine Sulfate ErMorphine Sulfate18$522
Methocarbamol23$433

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Liverpool

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →